Keywords
Barrett’s esophagus, gastroesophageal reflux disease, dyspepsia, esophagogastroduodenoscopy.
How to Cite
Svintsitskyy, A., Revenok, K., Solovyeva, G., & Korendovych, I. (2013). Barrett’s esophagus in patients without classic clinical manifestations of gastroesophageal reflux disease. The Practitioner, (4), 29-35. Retrieved from https://plr.com.ua/index.php/journal/article/view/406
Abstract
Barrett’s esophagus (BE) is a complication of gastroesophageal reflux disease (GERD) that increases the risk of adenocarcinoma development. In patients with GERD symptoms, BE is diagnosed in 3-20%, however up to 40% of cases is revealed in patients without previous reflux symptoms. Our study showed that there are no significant differences and no clear correlation in complaints between patients with functional dyspepsia and BE. BE can be diagnosed in a significant
percentage of asymptomatic patients and in patients without classic GERD complaints.
References
1. Barrett N.R. Chronic peptic ulcer of the oesophagus and “oesophagitis” / N.R.Barrett // Br. J. Surg. - 1950. - Vol. 38. - P. 175-182.
2. Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett’s esophagus / G.Sarosi, G.Brown,
K.Jaiswal [et al.] // Dis. Esophagus. - 2008. - Vol. 21. - P. 43-50.
3. Cigarette smoking increases risk of Barrett’s esophagus: an analysis of the Barrett’s and Esophageal Adenocarcinoma Consortium / M.B.Cook,
N.J.Shaheen, L.A.Anderson [et al.] // Gastroenterology. - 2012. - Vol. 142. - P. 744-753.
4. Delaney B. Helicobacter pylori and gastro-oesophageal reflux disease / B.Delaney, K.McColl // Aliment. Pharmacol. Ther. - 2005. - Vol. 22. - P.32-40.
5. Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective
study / M.Rossi, M.Barreca, N.de Bortoli [et al.] // Ann. Surg. - 2006. - Vol. 243. - P. 58-63.
6. Endoscopic characteristics of short-segment Barrett’s esophagus, focusing on squamous islands and mucosal folds / N.Ishimura, Y.Amano,
J.D.Sollano [et al.] // J. Gastroenterol. Hepatol. - 2012. - Vol. 27. - P. 82-87.
7. Gerson L.B. Prevalence of Barrett’s esophagus in asymptomatic individuals / L.B.Gerson, K.Shetler, G.Triadafilopoulos // Gastroenterology. - 2002.
- Vol. 123. - P. 461-467.
8. Hampel H. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications / H.Hampel, N.S.Abraham, H.B.El-Serag
// Ann. Intern. Med. - 2005. - Vol. 143. - P. 199-211.
9. Leukocyte telomere length predicts cancer risk in Barrett’s esophagus cancer / R.A.Risques, T.L.Vaughan, X.Li [et al.] // Epidemiol. Biomarkers.
Prev. - 2007. - Vol. 16. - P. 2649-2655.
10. Management of Helicobacter pylori infection - the Maastricht IV/ Florence Consensus Report / P.Malfertheiner, F.Megraud, C.A.O’Morain [et al.]
// Gut. - 2012. - Vol.61. - P. 646-664.
11. Medical or surgical management of GERD patients with Barrett’s esophagus: the LOTUS trial 3-year experience / S.E.Attwood, L.Lundell,
J.G.Hatlebakk [et al.] // Gastrointest. Surg. - 2008. - Vol. 12. - P. 1646-1654.
12. Obesity increases oesophageal acid exposure / H.B.El-Serag, G.A.Ergun, J.Pandolfino [et al.] // Gut. - 2007. - Vol. 56. - P. 749-755.
13. Prevalence of Barrett’s esophagus in the general population: an endoscopic study / J.Ronkainen, P.Aro, T.Storskrubb [et al.] // Gastroenterology.
- 2005. - Vol. 129. - P. 1825-1831.
14. Prevalence of columnar-lined (Barrett`s) esophagus. Comparision of population - based clinical and autopsy findings / A.J.Cameron, A.R.Zinsmeister,
D.J.Ballard [et al.] // Gastroenterology. - 1990. - Vol. 99. - P. 918-922.
15. Rajendra S. Human leucocyte antigen determinants of susceptibility to Barrett’s oesophagus in Asians - a preliminary study / S.Rajendra, R.Ackroyd
// Aliment. Pharmacol. Ther. - 2005. - Vol. 21. - P. 1377-1383.
2. Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett’s esophagus / G.Sarosi, G.Brown,
K.Jaiswal [et al.] // Dis. Esophagus. - 2008. - Vol. 21. - P. 43-50.
3. Cigarette smoking increases risk of Barrett’s esophagus: an analysis of the Barrett’s and Esophageal Adenocarcinoma Consortium / M.B.Cook,
N.J.Shaheen, L.A.Anderson [et al.] // Gastroenterology. - 2012. - Vol. 142. - P. 744-753.
4. Delaney B. Helicobacter pylori and gastro-oesophageal reflux disease / B.Delaney, K.McColl // Aliment. Pharmacol. Ther. - 2005. - Vol. 22. - P.32-40.
5. Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective
study / M.Rossi, M.Barreca, N.de Bortoli [et al.] // Ann. Surg. - 2006. - Vol. 243. - P. 58-63.
6. Endoscopic characteristics of short-segment Barrett’s esophagus, focusing on squamous islands and mucosal folds / N.Ishimura, Y.Amano,
J.D.Sollano [et al.] // J. Gastroenterol. Hepatol. - 2012. - Vol. 27. - P. 82-87.
7. Gerson L.B. Prevalence of Barrett’s esophagus in asymptomatic individuals / L.B.Gerson, K.Shetler, G.Triadafilopoulos // Gastroenterology. - 2002.
- Vol. 123. - P. 461-467.
8. Hampel H. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications / H.Hampel, N.S.Abraham, H.B.El-Serag
// Ann. Intern. Med. - 2005. - Vol. 143. - P. 199-211.
9. Leukocyte telomere length predicts cancer risk in Barrett’s esophagus cancer / R.A.Risques, T.L.Vaughan, X.Li [et al.] // Epidemiol. Biomarkers.
Prev. - 2007. - Vol. 16. - P. 2649-2655.
10. Management of Helicobacter pylori infection - the Maastricht IV/ Florence Consensus Report / P.Malfertheiner, F.Megraud, C.A.O’Morain [et al.]
// Gut. - 2012. - Vol.61. - P. 646-664.
11. Medical or surgical management of GERD patients with Barrett’s esophagus: the LOTUS trial 3-year experience / S.E.Attwood, L.Lundell,
J.G.Hatlebakk [et al.] // Gastrointest. Surg. - 2008. - Vol. 12. - P. 1646-1654.
12. Obesity increases oesophageal acid exposure / H.B.El-Serag, G.A.Ergun, J.Pandolfino [et al.] // Gut. - 2007. - Vol. 56. - P. 749-755.
13. Prevalence of Barrett’s esophagus in the general population: an endoscopic study / J.Ronkainen, P.Aro, T.Storskrubb [et al.] // Gastroenterology.
- 2005. - Vol. 129. - P. 1825-1831.
14. Prevalence of columnar-lined (Barrett`s) esophagus. Comparision of population - based clinical and autopsy findings / A.J.Cameron, A.R.Zinsmeister,
D.J.Ballard [et al.] // Gastroenterology. - 1990. - Vol. 99. - P. 918-922.
15. Rajendra S. Human leucocyte antigen determinants of susceptibility to Barrett’s oesophagus in Asians - a preliminary study / S.Rajendra, R.Ackroyd
// Aliment. Pharmacol. Ther. - 2005. - Vol. 21. - P. 1377-1383.
Downloads
Download data is not yet available.